Your search returned 2 results.

Results
	1.	A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability. [electronic resource] by ten Cate, B Bremer, E de Bruyn, M Bijma, T Samplonius, D Schwemmlein, M Huls, G Fey, G Helfrich, W Producer: 20090921 In: Leukemia vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells. [electronic resource] by Schwemmlein, M Stieglmaier, J Kellner, C Peipp, M Saul, D Oduncu, F Emmerich, B Stockmeyer, B Lang, P Beck, J D Fey, G H Producer: 20070831 In: Leukemia vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search